Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Doshi

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 9, 2025
Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodiesBhavya S Doshi, Caroline A Markmann, Noelle Novak, et al.
Metabolism: Clinical and Experimental|July 18, 2009
18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db miceRathinasabapathy Anandharajan, Sufyan G Sayyed, Lalit S Doshi, et al.
Cell Reports. Medicine|November 1, 2024
Degradation of IKZF1 prevents epigenetic progression of T cell exhaustion in an antigen-specific assayTristan Tay, Gayathri Bommakanti, Elizabeth Jaensch, et al.
American Journal of Epidemiology|September 7, 2012
The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009Saumil S Doshi, Kendra E Stauffer, Amy Parker Fiebelkorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2021
Phage-encoded ten-eleven translocation dioxygenase (TET) is active in C5-cytosine hypermodification in DNAEvan J Burke, Samuel S Rodda, Sean R Lund, et al.
Pain and Therapy|October 12, 2022
Efficacy and Safety of Pregabalin Prolonged Release-Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized StudyAmit B Yeole, G Sree Ranga Lakshmi, C J Selvakumar, et al.
AMB Express|November 23, 2011
Fermentation, Isolation, Structure, and antidiabetic activity of NFAT-133 produced by Streptomyces strain PM0324667Asha A Kulkarni-Almeida, Manoja K Brahma, Prabhu Padmanabhan, et al.
Molecular Cancer Therapeutics|March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination PartnersAatman S Doshi, Susan Cantin, Marylens Hernandez, et al.
Physical Review Letters|March 25, 2025
Increasing Octupole Collectivity across the Z=64 Isotopic Chain: B(E3) Values in ^{150}GdS Pascu, E Yüksel, Abhishek, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 9, 2025
Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodiesBhavya S Doshi, Caroline A Markmann, Noelle Novak, et al.
Metabolism: Clinical and Experimental|July 18, 2009
18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db miceRathinasabapathy Anandharajan, Sufyan G Sayyed, Lalit S Doshi, et al.
Cell Reports. Medicine|November 1, 2024
Degradation of IKZF1 prevents epigenetic progression of T cell exhaustion in an antigen-specific assayTristan Tay, Gayathri Bommakanti, Elizabeth Jaensch, et al.
American Journal of Epidemiology|September 7, 2012
The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009Saumil S Doshi, Kendra E Stauffer, Amy Parker Fiebelkorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2021
Phage-encoded ten-eleven translocation dioxygenase (TET) is active in C5-cytosine hypermodification in DNAEvan J Burke, Samuel S Rodda, Sean R Lund, et al.
Pain and Therapy|October 12, 2022
Efficacy and Safety of Pregabalin Prolonged Release-Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized StudyAmit B Yeole, G Sree Ranga Lakshmi, C J Selvakumar, et al.
AMB Express|November 23, 2011
Fermentation, Isolation, Structure, and antidiabetic activity of NFAT-133 produced by Streptomyces strain PM0324667Asha A Kulkarni-Almeida, Manoja K Brahma, Prabhu Padmanabhan, et al.
Molecular Cancer Therapeutics|March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination PartnersAatman S Doshi, Susan Cantin, Marylens Hernandez, et al.
Physical Review Letters|March 25, 2025
Increasing Octupole Collectivity across the Z=64 Isotopic Chain: B(E3) Values in ^{150}GdS Pascu, E Yüksel, Abhishek, et al.
Pageof 11